Angiotensin II and COVID-19. Secrets of interactions
Título
Angiotensin II and COVID-19. Secrets of interactions
Autor
A. O. Konradi, A. O. Nedoshivin
Descripción
The article describes current data on the relationship of renin-angiotensin system and related drugs with the risk of COVID-19 infection and its outcomes. Analysis of the latest publications did not reveal association of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers with any risk of an unfavorable outcomes, and there was no data for withdrawal of these drugs.
Fecha
2020
Materia
covid-19, angiotensin-converting enzyme 2, angiotensin converting enzyme inhibitors
Identificador
10.15829/1560-4071-2020-3861
Fuente
Российский кардиологический журнал
Editor
«FIRMA «SILICEA» LLC
Cobertura
Diseases of the circulatory (Cardiovascular) system
Archivos
Colección
Citación
A. O. Konradi, A. O. Nedoshivin, “Angiotensin II and COVID-19. Secrets of interactions,” SOCICT Open, consulta 18 de abril de 2026, https://socictopen.socict.org/items/show/6130.
Position: 8004 (28 views)